Business
Deferred Share Option Award to Executive Directors
Deferred Share Option Award to Executive Directors.
About this update from Eco Animal Health Group Plc
[{"type":"text","content":"\n\n29 August 2024\n\nECO Animal Health Group plc\n(\"ECO\" or the \"Company\")\n \nDeferred Share Option Awards to Executive Directors\n \nECO Animal Health Group plc (AIM: EAH), a rapidly growing global animal health company with a portfolio of marketed veterinary products and a maturing proprietary R&D pipeline, announces that on 28 August 2024 nominal cost share options were granted under the Company's Deferred Bonus Plan (\"DBS\") over 143,452 ordinary shares in the Company (representing approximately 0.21 percent of the Company's issued share capital) to two Executive Directors listed below. These awards relate to the deferral of 33% of the annual bonus for Executive Directors earned in respect of the Company's financial year ended 31 March 2024.\n \n\n\n\n\nName\n\n\nPosition\n\n\nNumber of Deferred Share Options\n\n\n\n\nDavid Hallas\n\n\nChief Executive Officer\n\n\n82,437\n\n\n\n\nChris Wilks\n\n\nChief Financial Officer\n\n\n61,015\n\n\n\n\n \nAs indicated in the Circular to shareholders dated 4 February 2021, the DBS has been established to allow the Remuneration Committee to require a significant part of the annual bonuses paid to Executive Directors to be deferred in exchange for an award of nominal cost options which vest after 3 years.\n \n-Ends-\nFor further information please contact:\n \n\n\n\n\n\n\n\n\nECO Animal Health Group plc\nDavid Hallas (CEO)\nChristopher Wilks (CFO)\n\n\n\n020 8447 8899\n \n\n\n\n\nSinger Capital Markets (Nominated Adviser & Joint Broker)\nPhil Davies\nSam Butcher\n\n\n020 7496 3000\n\n\n\n\nInvestec (Joint Broker)\nGary Clarence\nLydia Zychowska\n\n\n020 7597 5970\n \n \n\n\n\n\nEquity Development\nHannah Crowe\nMatt Evans\n\n\n020 7065 2692\n\n\n\n\nICR Consilium (Financial PR)\nMary-Jane Elliott\nJessica Hodgson\n\n\n020 3709 5700\[email protected]\n \n\n\n\n\n\n\n\n\n\n\n\n\nAbout ECO Animal Health\nECO Animal Health is a world leader in animal health, developing and marketing branded veterinary pharmaceuticals globally, with expertise in antibiotics and vaccines for pigs and poultry. We have a maturing proprietary R&D pipeline.\n \nHeadquartered in the UK, with global offices including R&D and manufacturing, we have marketing authorisations in over 70 countries and employ over 200 people wor...